Novelix Pharmaceuticals Ltd amended its EGM notice for a preferential share allotment due to regulatory non-compliance by two proposed allottees. The shares have been reallocated, and a name correction was also issued.
Novelix Pharmaceuticals Ltd: Corrigendum Issued for Preferential Allotment
Novelix Pharmaceuticals Ltd has issued a corrigendum to its EGM notice dated June 4, 2026, concerning the preferential allotment of 1,200,000 equity shares. The company is modifying the list of proposed allottees following observations from the BSE regarding regulatory non-compliance. ## What just happened Two proposed allottees, Sakshi Malani and Pallapothu Sivakrishna, have been removed from the preferential allotment list. Sakshi Malani was set to receive 150,000 shares and Pallapothu Sivakrishna 25,000 shares. These shares, totaling 175,000, will be re-allocated. ## Why this matters The disqualification impacts the composition of new shareholders and highlights the company's adherence to SEBI regulations. Investors should note the changes in the allotment structure. ## The backstory The issue arises from violations of Regulation 159(1)(c) of the SEBI (Issue of Capital and Disclosure Requirements) Regulations, 2018. The individuals disqualified sold shares within the 90-trading-day period before the relevant date, which is a breach of the regulations for proposed allottees. ## What changes now The 175,000 shares originally intended for the disqualified allottees will now be re-allocated to other parties. Additionally, a typographical error in an allottee's name has been corrected; 'PRAKASH GADLA' will now be officially recorded as 'PRAKASH GALDA'. ## Risks to watch Potential delays in the preferential allotment process or further regulatory scrutiny could pose risks. The company must ensure all future allotments strictly comply with SEBI guidelines. ## Peer comparison Preferential allotments are common fundraising methods. However, the strict enforcement of SEBI regulations means companies must be diligent in vetting allottees to avoid such disqualifications. ## Context metrics (time-bound) The EGM to discuss this revised allotment is scheduled for Wednesday, July 01, 2026, at 3:30 PM IST via Video Conferencing (VC) or Other Audio-Visual Means (OAVM). ## What to track next Investors should monitor the outcome of the EGM and the final list of allottees post-reallocation. Compliance with SEBI regulations will be key for future fundraising activities.
